China has seen a growing demand for clinical nutrition. The most viable reason for Nestle Health Science to invest in a product innovation center in Taizhou, Jiangsu province alongside other nutrition health brands in the country.
The establishment of this facility in China reflects the firm’s confidence and commitment to the Chinese market as well as the Asia-Pacific region.
Cecily Gu, business head of Nestle Health Sciences in China reveals that products manufactured here will be provided to the Chinese mainland consumers. Moreover, it will also be sold in Hong Kong and Taiwan.
Gu believes that the Product Innovation Center will continue to carry out localized innovations, develop formulas according to Chinese tastes and nutritional diet characteristics. This will allow more patients to receive nutritional treatment in order to narrow the gap in clinical nutrition treatment. She also added that they are looking into adding more locally adapted flavors to suit Chinese consumers.
Nutren Novasource GI, the first liquid whole protein nutrition formula, has been registered as a food for medical purpose in July 2019. She strongly feels that this breakthrough will bring clinical nutrition to a new level.
Moreover, global CEO of Nestle Health Science Group, Gregory Behar promises that they will provide cutting edge technical support and experience for Chinese consumers.
Nestle Health Sciences is a subsidiary of Nestle, the biggest food company in the world whose headquarters is in Switzerland to which the center will operate in parallel with. Both facilities will share localized innovations for China’s national standards and consumer needs to further enhance products under Foods for Special Medical Purpose in the country.
Nestle Health Sciences has been in the Chinese market for the last three years and has 11 approved formula products in China, including five for babies and infants and six for FSMP.
China has the largest number of senior residents in the world. Almost 180 million elderly people suffer from chronic diseases making the lifespan at 79 by the year 2030.
In its 2018 healthcare statistics report, over 250 million cases of in-hospital patients were revealed. Given such data, It will become necessary to provide effective and quality medical nutrition support moving forward.
